MYCOBACT 2024

4-6 September

The 11th International conference on the Pathogenesis of Mycobacterial Infections 2024

MYCOBACT 2024

4-6 September

The 11th International conference on the Pathogenesis of Mycobacterial Infections 2024

Program

Wednesday, September 4:

10.00-            Registration

12.50-13.00   Welcome, Local organizing committee

GENOMICS

13.00-13.35   Stefan Niemann, Research Center Borstel, Germany: Evolution and transmission of drug-resistant M. tuberculosis strains

13.40-14.15   Kirsten Bos, Max Planck Institute, Leipzig, Germany: M. pinnipedii in the pre-columbus era in Peru

14.20-14.40   Or01 (selected oral abstract)

14.40-14.55   Or02 (selected oral abstract)

15.00-15.30   COFFEE

CELL BIOLOGY & METABOLISM

15.30-16.05   Caroline Barisch, Center for Structural Systems Biology, Germany: Host-microbe interactome of M. marinum in model organisms

16.10-16.45    Amit Singhal, Singapore Immunology Network, Singapore: Metabolism and TB

16.50-17.05   Or03 (selected oral abstract)

17.05-17.20   Or04 (selected oral abstract)

KEYNOTE TALK

17.20-18.00    Katrin Mayer Barber, Laboratory of Clinical Immunology & Microbiology, NIH, USA: Mechanistic insights in TB disease

19:00-            MINGLE BUFFET and POSTER SESSION

 

Thursday, September 5:

HOST IMMUNE RESPONSE

08:30-09.05  Anca Dorhoi, Friedrich-Loeffler Institute, Germany: Immunoregulation in TB

09.10-09.45   Olivier Neyrolles, IPBS-Toulouse, France: Unveiling Lung Innervation in TB Granulomas and Beyond

09.50-10.05   Or04 (selected oral abstract)

10.05-10.20   Or05 (selected oral abstract)

10.25-10.55   COFFEE

10.55-11.30   Al Leslie, Africa Health Research Institute, Durban, South Africa: T cell immunity in the TB granuloma

11.30-12.05   Christne Stabell Benn, University of Southern Denmark, Denmark: BCG vaccine-induced specific and non-specific effects

12.10-13.15    LUNCH at Stallmästaregården

 

DIAGNOSIS AND VACCINES

13.15-13.50   Annemieke Geluk, Leiden University, the Netherlands: Immunodiagnostics of mycobacterial diseases

13.55-14.30   Mahdad Noursadeghi, University College, London, UK: Biomarkers in diagnosis of TB

14.35-14.50   Or07

15.25-16.00   COFFEE

16.00-16.35      Iman Satti, The Jenner Institute, University of Oxford, UK: Mucosal vaccines in TB

16.40-17.15   Thomas Lindenstrom, Statens Serum Institut, Denmark: T cell immunity with relevance for TB vaccine development

16.40-16.55   Or08

19.00-            CONFERENCE DINNER

 

Friday, September 6:

CLINICAL MANAGEMENT

08.30-09.05   Jakko van Ingen, Radboud University Nijmegen Medical Center, the Netherlands: Management of non-tuberculous mycobacteria

09.10-09.45   Anneke Hesseling, Desmond Tutu TB Centre at Stellenbosch University, South Africa: Management of pediatric TB

09.50-10.05   Or09

10.05-10.20   Or10

10.25-10.55    COFFEE

10.55-11.30   Robert Wilkinson, University of Cape Town, South Africa/Crick Institute, UK: Recent advances in TB treatment

11.30-12.05   Francisco Roca, University of Murcia, Spain: Host-directed therapies for TB

12.05-12.10    Closure (organizing committee)

Contact

Conference Secretariat

For practical questions please contact Academic Conferences.

Phone: +46 18 671003
Email: mycobact2024@akademikonferens.se

Akademikonferens. Logotyp.

Important dates

  • Deadline for abstract submission: July 3, 2024
  • Last date for guaranteed hotel reservation: July 15, 2024
  • Deadline for registration: Aug 1, 2024
  • Notification sent to abstract authors:  July 31, 2024
  • Deadline for registration cancellation: Aug 1, 2024
  • Deadline for hotel cancellation: Aug 1, 2024

 

Organizers